Panacea Biotec Ltd Performance
Day's Low
Day's High
₹400₹41852 Week's Low
52 Week's High
₹112.35₹418
| Returns % | |
| 1 Month Return | + 33.44 % |
| 3 Month Return | + 104.8 % |
| 1 Year Return | + 162.4 % |
| Market Stats | |
| Previous Close | ₹414.00 |
| Open | ₹413.30 |
| Volume | 1.20L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹2,535.78Cr |
Panacea Biotec Ltd Key Statistics
| P/E Ratio | -169.42 |
| PEG Ratio | 42.46 |
| Market Cap | ₹2,535.78 Cr |
| P/B Ratio | 2.42 |
| EPS | -0.25 |
| Dividend Yield | 0 |
| Sector | Pharmaceuticals |
| ROE | 0.86 |
Panacea Biotec Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹2,535.78 Cr | 49.97% | 0.65 | -₹2 Cr | ₹559 Cr | |
| NA | ₹44.02 Cr | 1.53% | 0.58 | NA | NA | |
| NA | ₹260.52 Cr | 273.93% | 0.58 | -₹12 Cr | ₹15 Cr | |
| NA | ₹286.75 Cr | 122.28% | 0.66 | ₹5 Cr | ₹155 Cr | |
| NA | ₹15,763.63 Cr | 26.32% | 0.51 | NA | NA |
About Panacea Biotec Ltd
Share Price: ₹410.00 per share as on 22 Nov, 2024 04:01 PM
Market Capitalisation: ₹2,535.78Cr as of today
Revenue: ₹147.35Cr as on September 2024 (Q3 24)
Net Profit: ₹4.71Cr as on September 2024 (Q3 24)
Listing date: 17 Apr, 1996
Chairperson Name: Rajesh Jain
| Organisation | Panacea Biotec Ltd |
| Headquarters | New Delhi |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Panacea Biotec Ltd
Panacea Biotec Shares Rise on Dengue Vaccine News - 11 Oct, 2024
Panacea Biotec's shares surged 4% following the announcement of plans to launch a dengue vaccine within 2-3 years, currently in phase three trials across India.
Panacea Biotec Shares Surge Amid Positive Developments - 10 Oct, 2024
Panacea Biotec shares hit the 5% upper circuit limit at ₹304.35, driven by ongoing dengue vaccine development and a recent legal settlement with Sanofi. The stock has risen 108% over the past six months.
Panacea Biotec Reaches Settlement, Stock Soars - 17 Sep, 2024
Panacea Biotec shares surged to a 52-week high after settling a patent dispute with Sanofi Healthcare, resulting in a significant price increase and multibagger returns.
Panacea Biotec Settles Patent Dispute with Sanofi - 16 Sep, 2024
Panacea Biotec Ltd. has settled a patent infringement dispute with Sanofi Healthcare India regarding its EasySix vaccine. The resolution was reached through a joint application to the Delhi High Court, concluding the case on September 13, 2024.
Panacea Biotec Secures $20 Million for Expansion - 13 Sep, 2024
Panacea Biotec Limited has received a $20 million loan from the US International Development Finance Corporation to expand its manufacturing capacity for the EasySix hexavalent vaccine. The stock hit a 5% upper circuit after the announcement, reflecting positive investor sentiment.
Insights on Panacea Biotec Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 7 days, PANACEABIO stock has moved up by 9.2%
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, PANACEABIO has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, PANACEABIO has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -15.88 Cr → 4.71 Cr (in ₹), with an average increase of 437.2% per quarter
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 25.20% to 25.60% in Sep 2024 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 122.26 Cr → 154.77 Cr (in ₹), with an average increase of 21.0% per quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 0.27% to 0.37% in Sep 2024 quarter
NEGATIVE IMPACTPromoter Holding Down
Promoters have decreased holdings from 73.46% to 72.87% in Sep 2024 quarter
Panacea Biotec Ltd Financials
Panacea Biotec Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 72.87% | ||
| Foreign Institutions | 0.37% | 38.60 | |
| Mutual Funds | 0% | ||
| Retail Investors | 25.6% | 1.57 | |
| Others | 1.16% | 9.19 |
Panacea Biotec Ltd Key Indicators
Panacea Biotec Ltd Valuation
Panacea Biotec Ltd in the last 5 years
Lowest (-915.62x)
April 25, 2024
Today (-169.42x)
November 22, 2024
Industry (54.77x)
November 22, 2024
Highest (113.15x)
October 5, 2023
Panacea Biotec Ltd Earnings and Dividends
Panacea Biotec Ltd Earnings Results
Panacea Biotec Ltd’s net profit jumped 156.82% since last year same period to ₹4.71Cr in the Q2 2024-2025. On a quarterly growth basis, Panacea Biotec Ltd has generated 129.66% jump in its net profits since last 3-months.
Read More about Earnings Results
Panacea Biotec Ltd Technicals Summary
Bearish
Neutral
Bullish
Panacea Biotec Ltd is currently in a Bullish trading position according to technical analysis indicators.
FAQs on Panacea Biotec Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Panacea Biotec Ltd shares.
Panacea Biotec Ltd (PANACEABIO) share price today is ₹410
Panacea Biotec Ltd is listed on NSE
Panacea Biotec Ltd is listed on BSE
- Today’s highest price of Panacea Biotec Ltd is ₹418.
- Today’s lowest price of Panacea Biotec Ltd is ₹400.
PE Ratio of Panacea Biotec Ltd is -169.42
PE ratio = Panacea Biotec Ltd Market price per share / Panacea Biotec Ltd Earnings per share
Today’s traded volume of Panacea Biotec Ltd(PANACEABIO) is 1.20L.
Today’s market capitalisation of Panacea Biotec Ltd(PANACEABIO) is ₹2535.78Cr.
| Panacea Biotec Ltd(PANACEABIO | Price |
|---|---|
52 Week High | ₹418 |
52 Week Low | ₹112.35 |
Panacea Biotec Ltd(PANACEABIO) share price is ₹410. It is down -1.91% from its 52 Week High price of ₹418
Panacea Biotec Ltd(PANACEABIO) share price is ₹410. It is up 264.93% from its 52 Week Low price of ₹112.35
| Panacea Biotec Ltd(PANACEABIO | Returns |
|---|---|
1 Day Returns | -4% |
1 Month Returns | 33.44% |
3 Month Returns | 104.8% |
1 Year Returns | 162.4% |